197 related articles for article (PubMed ID: 20531015)
1. Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.
Sezgin E; Hendrickson SL; Jabs DA; Van Natta ML; Lewis RA; Troyer JL; O'Brien SJ;
J Acquir Immune Defic Syndr; 2010 Aug; 54(4):343-51. PubMed ID: 20531015
[TBL] [Abstract][Full Text] [Related]
2. Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival.
Hendrickson SL; Jacobson LP; Nelson GW; Phair JP; Lautenberger J; Johnson RC; Kingsley L; Margolick JB; Detels R; Goedert JJ; O'Brien SJ
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):263-71. PubMed ID: 18391751
[TBL] [Abstract][Full Text] [Related]
3. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
Li H; Liu TJ; Hong ZH
Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
[TBL] [Abstract][Full Text] [Related]
4. Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.
Sezgin E; van Natta ML; Ahuja A; Lyon A; Srivastava S; Troyer JL; O'Brien SJ; Jabs DA;
Am J Ophthalmol; 2011 Jun; 151(6):999-1006.e4. PubMed ID: 21396623
[TBL] [Abstract][Full Text] [Related]
5. Modulating influence on HIV/AIDS by interacting RANTES gene variants.
An P; Nelson GW; Wang L; Donfield S; Goedert JJ; Phair J; Vlahov D; Buchbinder S; Farrar WL; Modi W; O'Brien SJ; Winkler CA
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10002-7. PubMed ID: 12114533
[TBL] [Abstract][Full Text] [Related]
6. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India.
Suresh P; Wanchu A; Sachdeva RK; Bhatnagar A
J Clin Immunol; 2006 Sep; 26(5):476-84. PubMed ID: 16865553
[TBL] [Abstract][Full Text] [Related]
8. Distribution of CCR5-Delta32, CCR2-64I, SDF1-3'A, CX3CR1-249I, and CX3CR1-280M in Chinese populations.
Qian Y; Sun H; Lin K; Shi L; Shi L; Chu J
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1391-7. PubMed ID: 19032065
[TBL] [Abstract][Full Text] [Related]
9. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
[TBL] [Abstract][Full Text] [Related]
10. RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs.
Koizumi Y; Kageyama S; Fujiyama Y; Miyashita M; Lwembe R; Ogino K; Shioda T; Ichimura H
AIDS Res Hum Retroviruses; 2007 May; 23(5):713-9. PubMed ID: 17530998
[TBL] [Abstract][Full Text] [Related]
11. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.
McDermott DH; Beecroft MJ; Kleeberger CA; Al-Sharif FM; Ollier WE; Zimmerman PA; Boatin BA; Leitman SF; Detels R; Hajeer AH; Murphy PM
AIDS; 2000 Dec; 14(17):2671-8. PubMed ID: 11125885
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
[TBL] [Abstract][Full Text] [Related]
13. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
Smith MW; Dean M; Carrington M; Winkler C; Huttley GA; Lomb DA; Goedert JJ; O'Brien TR; Jacobson LP; Kaslow R; Buchbinder S; Vittinghoff E; Vlahov D; Hoots K; Hilgartner MW; O'Brien SJ
Science; 1997 Aug; 277(5328):959-65. PubMed ID: 9252328
[TBL] [Abstract][Full Text] [Related]
14. Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.
Geskus RB; Meyer L; Hubert JB; Schuitemaker H; Berkhout B; Rouzioux C; Theodorou ID; Delfraissy JF; Prins M; Coutinho RA
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):321-6. PubMed ID: 15980693
[TBL] [Abstract][Full Text] [Related]
15. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
Ioannidis JP; Rosenberg PS; Goedert JJ; Ashton LJ; Benfield TL; Buchbinder SP; Coutinho RA; Eugen-Olsen J; Gallart T; Katzenstein TL; Kostrikis LG; Kuipers H; Louie LG; Mallal SA; Margolick JB; Martinez OP; Meyer L; Michael NL; Operskalski E; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Stewart GJ; Theodorou ID; Ullum H; Vicenzi E; Vlahov D; Wilkinson D; Workman C; Zagury JF; O'Brien TR;
Ann Intern Med; 2001 Nov; 135(9):782-95. PubMed ID: 11694103
[TBL] [Abstract][Full Text] [Related]
16. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.
Ramana GV; Vasanthi A; Khaja M; Su B; Govindaiah V; Jin L; Singh L; Chakraborty R
J Genet; 2001 Dec; 80(3):137-40. PubMed ID: 11988632
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.
Branch AD; Drye LT; Van Natta ML; Sezgin E; Fishman SL; Dieterich DT; Meinert CL; Jabs DA
Clin Infect Dis; 2013 Dec; 57(11):1618-25. PubMed ID: 24081683
[TBL] [Abstract][Full Text] [Related]
18. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
Martin MP; Dean M; Smith MW; Winkler C; Gerrard B; Michael NL; Lee B; Doms RW; Margolick J; Buchbinder S; Goedert JJ; O'Brien TR; Hilgartner MW; Vlahov D; O'Brien SJ; Carrington M
Science; 1998 Dec; 282(5395):1907-11. PubMed ID: 9836644
[TBL] [Abstract][Full Text] [Related]
19. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
[TBL] [Abstract][Full Text] [Related]
20. The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users.
Duggal P; Winkler CA; An P; Yu XF; Farzadegan H; O'Brien SJ; Beaty TH; Vlahov D
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):584-9. PubMed ID: 15793370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
